Trials / Recruiting
RecruitingNCT06980376
Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes
Effects of Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes: A Multi-Centre, Randomised, Open-Label, Prospective Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- a2 Milk Company Ltd. · Industry
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to compare the effects of conventional Ultra High Temperature (UHT) milk containing both A1 and A2 type β-caseins (CON) with a2 UHT Milk containing A2 type β-casein only (A1PF) on inflammation, tolerance, and GI symptoms in pregnant women as well as infants' birth outcomes from 12 weeks' gestation up to 40 days post-birth.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | a2 UHT milk | Pregnant women in this arm will drink a2 UHT Milk twice a day, 200ml each time, until study completion. Their infants will be fed with the mother's breastmilk exclusively. |
| OTHER | Conventional UHT Milk | Pregnant women in this arm will drink conventional UHT Milk twice a day, 200ml each time, until study completion. Their infants will be fed with the mother's breastmilk exclusively. |
Timeline
- Start date
- 2025-08-25
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2025-05-20
- Last updated
- 2026-02-06
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06980376. Inclusion in this directory is not an endorsement.